BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 37151423)

  • 1. A small circulating miRNAs signature predicts mortality and adverse cardiovascular outcomes in chronic hemodialysis patients.
    Bolignano D; Greco M; Presta P; Duni A; Vita C; Pappas E; Mirabelli M; Lakkas L; Naka KK; Brunetti A; Foti DP; Andreucci M; Coppolino G; Dounousi E
    Clin Kidney J; 2023 May; 16(5):868-878. PubMed ID: 37151423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating miRNA 122-5p Expression Predicts Mortality and Cardiovascular Events in Chronic Hemodialysis Patients: A Multicentric, Pilot, Prospective Study.
    Duni A; Greco M; Presta P; Arena R; Pappas E; Lakkas L; Naka KK; Brunetti A; Foti DP; Andreucci M; Coppolino G; Dounousi E; Bolignano D
    Biomolecules; 2023 Nov; 13(11):. PubMed ID: 38002345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic and prognostic value of miR-486-5p, miR-451a, miR-21-5p and monocyte to high-density lipoprotein cholesterol ratio in patients with acute myocardial infarction.
    Xu L; Tian L; Yan Z; Wang J; Xue T; Sun Q
    Heart Vessels; 2023 Mar; 38(3):318-331. PubMed ID: 36214846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential expression profiles of microRNAs as potential biomarkers for the early diagnosis of lung cancer.
    Zhang Y; Sui J; Shen X; Li C; Yao W; Hong W; Peng H; Pu Y; Yin L; Liang G
    Oncol Rep; 2017 Jun; 37(6):3543-3553. PubMed ID: 28498428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of Circulating MicroRNAs Linked to Bone Metabolism in Chronic Kidney Disease-Mineral and Bone Disorder.
    Yavropoulou MP; Vaios V; Makras P; Georgianos P; Batas A; Tsalikakis D; Tzallas A; Ntritsos G; Roumeliotis S; Eleftheriadis T; Liakopoulos V
    Biomedicines; 2020 Dec; 8(12):. PubMed ID: 33322822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA expression in circulating microvesicles predicts cardiovascular events in patients with coronary artery disease.
    Jansen F; Yang X; Proebsting S; Hoelscher M; Przybilla D; Baumann K; Schmitz T; Dolf A; Endl E; Franklin BS; Sinning JM; Vasa-Nicotera M; Nickenig G; Werner N
    J Am Heart Assoc; 2014 Oct; 3(6):e001249. PubMed ID: 25349183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-small cell lung cancer associated microRNA expression signature: integrated bioinformatics analysis, validation and clinical significance.
    Li C; Yin Y; Liu X; Xi X; Xue W; Qu Y
    Oncotarget; 2017 Apr; 8(15):24564-24578. PubMed ID: 28445945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-451a, microRNA-34a-5p, and microRNA-221-3p as predictors of response to antidepressant treatment.
    Kuang WH; Dong ZQ; Tian LT; Li J
    Braz J Med Biol Res; 2018; 51(7):e7212. PubMed ID: 29791588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating microRNAs Related to Bone Metabolism in HIV-Associated Bone Loss.
    Yavropoulou MP; Kolynou A; Makras P; Pikilidou M; Nanoudis S; Skoura L; Tsachouridou O; Ntritsos G; Tzallas A; Tsalikakis DG; Tsave O; Metallidis S; Chatzidimitriou D
    Biomedicines; 2021 Apr; 9(4):. PubMed ID: 33924204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cathepsin-K is a potential cardiovascular risk biomarker in prevalent hemodialysis patients.
    Bolignano D; Greco M; Arcidiacono V; Tripolino O; Vita C; Provenzano M; Donato C; Chiarella S; Fuiano G; De Sarro G; Russo E; Andreucci M; Foti DP; Coppolino G
    Int Urol Nephrol; 2021 Jan; 53(1):171-175. PubMed ID: 32794117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of non-invasive biomarkers for chronic atrophic gastritis from serum exosomal microRNAs.
    Liu H; Li PW; Yang WQ; Mi H; Pan JL; Huang YC; Hou ZK; Hou QK; Luo Q; Liu FB
    BMC Cancer; 2019 Feb; 19(1):129. PubMed ID: 30736753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating serum microRNAs including senescent miR-31-5p are associated with incident fragility fractures in older postmenopausal women with type 2 diabetes mellitus.
    Heilmeier U; Hackl M; Schroeder F; Torabi S; Kapoor P; Vierlinger K; Eiriksdottir G; Gudmundsson EF; Harris TB; Gudnason V; Link TM; Grillari J; Schwartz AV
    Bone; 2022 May; 158():116308. PubMed ID: 35066213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating miRNA levels differ with respect to carotid plaque characteristics and symptom occurrence in patients with carotid artery stenosis and provide information on future cardiovascular events.
    Badacz R; Przewłocki T; Gacoń J; Stępień E; Enguita FJ; Karch I; Żmudka K; Kabłak-Ziembicka A
    Postepy Kardiol Interwencyjnej; 2018; 14(1):75-84. PubMed ID: 29743907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum microRNAs are key predictors of long-term heart failure and cardiovascular death after myocardial infarction.
    Rincón LM; Rodríguez-Serrano M; Conde E; Lanza VF; Sanmartín M; González-Portilla P; Paz-García M; Del Rey JM; Menacho M; García Bermejo ML; Zamorano JL
    ESC Heart Fail; 2022 Oct; 9(5):3367-3379. PubMed ID: 35837763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma miRNAs improve the prediction of coronary atherosclerosis in patients with rheumatoid arthritis.
    Ormseth MJ; Solus JF; Sheng Q; Chen SC; Ye F; Wu Q; Oeser AM; Allen R; Raggi P; Vickers KC; Stein CM
    Clin Rheumatol; 2021 Jun; 40(6):2211-2219. PubMed ID: 33389220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-146a-5p, miR-223-3p and miR-142-3p as Potential Predictors of Major Adverse Cardiac Events in Young Patients with Acute ST Elevation Myocardial Infarction-Added Value over Left Ventricular Myocardial Work Indices.
    Scărlătescu AI; Barbălată T; Sima AV; Stancu C; Niculescu LȘ; Micheu MM
    Diagnostics (Basel); 2022 Aug; 12(8):. PubMed ID: 36010296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum miRNA Signature in Rheumatoid Arthritis and "At-Risk Individuals".
    Cunningham CC; Wade S; Floudas A; Orr C; McGarry T; Wade S; Cregan S; Fearon U; Veale DJ
    Front Immunol; 2021; 12():633201. PubMed ID: 33746971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Panel of MicroRNA Signature as a Tool for Predicting Survival of Patients with Urothelial Carcinoma of the Bladder.
    Inamoto T; Uehara H; Akao Y; Ibuki N; Komura K; Takahara K; Takai T; Uchimoto T; Saito K; Tanda N; Yoshikawa Y; Minami K; Hirano H; Nomi H; Kato R; Hayashi T; Azuma H
    Dis Markers; 2018; 2018():5468672. PubMed ID: 30026881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombosis-related circulating miR-16-5p is associated with disease severity in patients hospitalised for COVID-19.
    Eyileten C; Wicik Z; Simões SN; Martins-Jr DC; Klos K; Wlodarczyk W; Assinger A; Soldacki D; Chcialowski A; Siller-Matula JM; Postula M
    RNA Biol; 2022 Jan; 19(1):963-979. PubMed ID: 35938548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA Expression in Circulating Leukocytes and Bioinformatic Analysis of Patients With Moyamoya Disease.
    Kang K; Shen Y; Zhang Q; Lu J; Ju Y; Ji R; Li N; Wu J; Yang B; Lin J; Liang X; Zhang D; Zhao X
    Front Genet; 2022; 13():816919. PubMed ID: 35669195
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.